Methicillin-resistant Staphylococcus aureus (MRSA) is currently one of the principal multiple drug resistant bacterial pathogens causing serious infections, many of which are life-threatening. Consequently, new therapeutic targets are required to combat such infections. In the current work, we explore the type 2 Nicotinamide adenine dinucleotide reduced form (NADH) dehydrogenases (NDH-2s) as possible drug targets and look at the effects of phenothiazines, known to inhibit NDH-2 from Mycobacterium tuberculosis. NDH-2s are monotopic membrane proteins that catalyze the transfer of electrons from NADH via flavin adenine dinucleotide (FAD) to the quinone pool. They are required for maintaining the NADH/Nicotinamide adenine dinucleotide (NAD + ) redox balance and contribute indirectly to the generation of proton motive force. NDH-2s are not present in mammals, but are the only form of respiratory NADH dehydrogenase in several pathogens, including S. aureus. In this work, the two putative ndh genes present in the S. aureus genome were identified, cloned and expressed, and the proteins were purified and characterized. Phenothiazines were shown to inhibit both of the S. aureus NDH-2s with half maximal inhibitory concentration (IC 50 ) values as low as 8 μM. However, evaluating the effects of phenothiazines on whole cells of S. aureus was complicated by the fact that they are also acting as uncouplers of oxidative phosphorylation. This article is part of a Special Issue entitled: 18th European Bioenergetic Conference. j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / b b a b i o
Introduction
Persistent infections involving slow-growing or non-growing bacteria are hard to treat with antibiotics that target biosynthetic processes in growing cells [1] . Consequently, the discoveries of new drugs that disrupt membrane function (including membrane potential and energy metabolism) have been the focus of attention [2] . An example of this is the diarylquinoline TMC207, which inhibits the membranebound ATP synthase in Mycobacterium tuberculosis [3] , and is the first antitubercular drug approved in 40 years (released by Johnson & Johnson). Oxidative phosphorylation is driven by the transmembrane proton motive force which is, in turn, generated by electron transfer through the respiratory chain. The respiratory enzymes of human pathogens present additional potential drug targets to disable their ability to generate energy.
Bacteria contain three distinct families of respiratory NADH:quinone oxidoreductases: Complex I, NDH-2, and a Na + -pumping Nqr complex [4] [5] [6] [7] . NDH-2s are composed of a single subunit of around 50 kDa with a non-covalently bound FAD as a cofactor. They are monotopic membrane proteins, being attached to the membrane through amphiphilic helices in the C-terminus [6, 8] . NDH-2 catalyzes the transfer of electrons from NADH via FAD to membrane-bound quinone, helps to maintain the NADH/NAD + redox balance, and contributes indirectly to the generation of proton motive force [9] . The crystal structure of a yeast NDH-2 (Ndi1) was recently solved, demonstrating that the protein is a homodimer with an amphiphilic membrane-anchor domain [6] . Since NDH-2s are present only in bacteria and certain plant, fungal and protozoan mitochondria, but not in mammals [10] [11] [12] [13] , they are an attractive drug target and have been recognized as such for Mycobacterium tuberculosis [14] [15] [16] [17] , Plasmodium falciparum [18] and Toxoplama gondii [13, 19] . Particularly susceptible to this drug strategy should be those pathogenic bacteria and parasites in which NDH-2 is the only respiratory NADH dehydrogenase present [13, 18] . This includes Staphylococcus aureus.
Methicillin-resistant S. aureus (MRSA) is one of the principal multiple drug resistant bacterial pathogens causing serious life-threatening infections [20] . Very little is known about the biochemistry of the respiratory chain components of S. aureus. Analysis of the genome indicates that two types of respiratory oxygen reductases are found in S. aureus cells, one bd-type menaquinol oxidase and one heme-copper aa 3 -type menaquinol oxidase. There is no bc 1 complex in S. aureus and no cytochrome c oxidase. L-lactate, succinate and NADH dehydrogenase activities have been detected in S. aureus membranes [21] [22] [23] [24] [25] as well as ATP synthase activity which can be inhibited by diarylquinolines related to the anti-TB drug TMC207 [26] . S. aureus has no Complex I (type-I
Construction of expression plasmids
The gene encoding NdhF (SAB0804c) and NdhC (SAB0807) from S. aureus RF122 strain (Dr. Stefan Monecke) was cloned into pET22b (Ap r , Novagen). To facilitate purification, an 8His-tag was introduced either in the N-or C-terminal of the ndhF and ndhC genes. The primers contained the His-tag and NdeI-HindIII restriction sites for the posterior cloning in pET22b. NdhF-Fw (5′-GGAATTCCATATGCATCACCATCACCAT CACCATCACAAAAACTTAGTTTTGTTAGGCGG-3′) and NdhF-Rv (5′-CCC AAGCTTTTAACCATTATGATATTTATATAACCAAAGTACG-3′). NdhC-Fw (5′-GGAATTCCATATGGCTCAAGATCGTAAAAAAGTACT-3′) and NdhC-Rv (5′-CCCAAGCTTCTAGTGATGGTGATGGTGATGGTGGAATTTACCTTTT TTGAATGCTAAAC-3′). For heterologous expression, the constructions in pET22b were transformed into Escherichia coli C43 (DE3) strain (Avidis, France), also containing pRARE for expression of rare codons (Km r ) [31] .
Cell growth, enzyme expression and purification
E. coli C43 (DE3) was grown in LB medium plus 100 μg/ml ampicillin and 50 μg/ml kanamycin, at 37°C and gene expression was induced by the addition of 1 mM IPTG (isopropyl-D-thiogalactoside) when cells reached an OD 600 of~0.7. All the purification procedures were carried out at 0-4°C. Cells were harvested and resuspended in buffer A (50 mM sodium phosphate, pH 7.5, 300 mM NaCl) with 5 mM MgSO 4 , DNAse I and a protease inhibitor cocktail (Sigma). They were then disrupted by passing twice through a microfluidizer at a pressure of 80,000 psi. Cell extract was centrifuged at 14,000 ×g for 10 min to remove the unbroken cells. Membranes were obtained after centrifugation at 230,000 ×g for 4 h. Pellets were resuspended in buffer A plus the protease inhibitor cocktail, and then solubilized by the addition of a stock solution of 20% DDM (dodecyl-β-D-maltoside) dropwise to a final concentration of 1%. The solution was incubated at 4°C for 2 h with mild agitation. The suspension was cleared by centrifugation at 230,000 ×g for 1 h. The supernatant was added to Ni-NTA resin (Qiagen) pre-equilibrated with buffer A plus 0.05% DDM. The resin was washed with buffer A plus 0.05% DDM and 10-20 mM histidine and then the bound proteins were eluted with buffer A with 0.05% DDM and 100 mM histidine. Fractions were concentrated by filtration, and then the histidine was removed by dialysis against buffer A plus 0.05% DDM. The purified protein could be stored frozen at − 80°C after the addition of glycerol to a final concentration of 10%.
Analytical methods
The protein purity was evaluated by SDS-PAGE using a 4-20% gradient gel (Nusep). Protein concentration was determined using the BCA kit (Thermo Scientific, Pierce Protein Research Products). The FAD content of the isolated protein was determined spectroscopically with an Agilent Technologies spectrophotometer (model 8453), using an extinction coefficient of 11.3 cm −1 mM −1 for the free oxidized flavin at 450 nm [32] , after extraction from the protein by treatment of the sample with 5% trichloroacetic acid [33] .
Membrane preparations
Bacterial cells were grown in LB plus 30 mM Na-succinate for 2 or 8 h, as indicated. E. coli membrane preparations were carried out as described above. S. aureus membranes were obtained by incubating cells with lysostaphin for 2 h at 37°C and then passing them twice through a microfluidizer at a pressure of 80,000 psi. The cell extract was centrifuged at 14,000 ×g for 10 min to remove the unbroken cells. Membranes were obtained by centrifugation at 230,000 ×g for 4 h. Pellets were resuspended in buffer A containing 10% glycerol to 30-40 mg/ml of protein and the suspension was stored at −80°C. The respiration rates are expressed as μmol O 2 mg protein −1 s −1 .
Steady state enzymatic activity assays

Method I: NADH dehydrogenase activity
The rate of NADH oxidation was measured at 37°C. The 200 μl reaction mixture contained 50 mM sodium phosphate buffer, pH 7.5, 50-300 mM NaCl, 0.05% DDM, 20 μM FAD, 125 μg/ml asolectin, 0-150 μM quinone and 1-3 μg of the purified NdhF or 0.06-0.2 μg NdhC. The reaction was started with the addition of 25-250 μM NADH (prepared freshly in buffer) and the reaction's progress was monitored by the decrease in absorption of NADH at 340 nm using an Agilent 8453 UV-vis spectrophotometer. The extinction coefficient of 6.22 cm −1 mM −1 at 340 nm was used for the absorption of NADH.
Method II: Oxygen consumption
Oxygen concentration was monitored using a YSI model 53 oxygen electrode (Yellow Springs Instrument Co., Yellow Springs, OH) equipped with a temperature-controlled 1.8-ml electrode chamber at 37°C. The reaction mixture for this assay consisted of sodium phosphate buffer, pH 7.5, 50-300 mM NaCl, 20 μM FAD and 200-400 μg/ml membranes and diluted isolated NdhC (0.06-0.2 μg) or NdhF (1-3 μg) enzymes. The concentration of oxygen in the air-saturated buffer at this temperature was assumed to be 250 μM, and the reaction was initiated by injecting 200 μM NADH.
Determination of kinetic constants
Kinetic parameters were determined using nonlinear least square analysis (Origin8.0) of the data fitted to the Michaelis-Menten rate equation (v = V max (S) / (K m + S)), where v is the velocity, V max is the maximum velocity, S is the substrate concentration and K m is the Michaelis-Menten constant. The enzyme rates are expressed as k cat , mol NADH oxidized or mol O 2 (mol enzyme) − 1 s − 1 . For testing inhibitors, the enzyme, in the presence of the quinone substrate (soluble analogues or membrane bound) was incubated in the reaction mix with different concentrations of the inhibitors for 3 min before NADH addition.
Membrane potential measurements
The transmembrane electrical potential (inside negative) was determined by the quenching of the potential-sensitive fluorescent probe 3,3′-dipropylthiodicarbocyanine (DisC3 (5)). This lipophilic cationic dye accumulates according to the Nernst equation with high concentrations in the electrically negative phase. At high concentrations, the dye aggregates and the normal fluorescence are quenched [34, 35] . Collapse of the membrane potential reverses the process and the fluorescence increases.
To perform this assay, cells of Newman strain [36] were grown for 2 h in LB and diluted to an OD 600 nm of 0.3 in LB plus 10 mM glucose.
Different concentrations of thioridazine (TZ) were added to the bacterial suspension as indicated. Changes in fluorescence due to the disruption of the Δψ were continuously monitored with a fluorescence spectrophotometer (Cary Eclipse, Agilent Technologies) employing an excitation wavelength of 643 nm and an emission wavelength of 666 nm at 30°C. The magnitude of the Δψ was not quantified.
Drug susceptibility determination
The minimum inhibitory concentration (MIC) of phenothiazines on the growth of S. aureus was determined by starting with an overnight culture grown in LB medium, diluted to an OD 600 nm of 0.005, and incubated for 20 h in the presence of the drugs in microliter plates (200 μl of LB medium in 360 μl wells). The MIC reported is the lowest concentration of the phenothiazine that yields no visible growth after incubation at 37°C, 200 rpm for 20 h.
ATP/ADP determination
S. aureus cells (Newman strain) were grown for 2 h in LB and concentrated in the same medium to an OD 600 nm of 2. Different concentrations of TZ, as indicated, were added and the ATP/ADP ratios were determined after 10 and 60 min of incubation at 37°C, 200 rpm. ATP and ADP were extracted from 50 μl cell suspension by adding trichloroacetic acid (TCA) to a final concentration of 0.5%. After 5 min, TAE (Tris-acetic acid-EDTA) buffer was added to neutralize the pH by diluting the sample 5-fold. The cell content of ATP and ADP was measured according to the manufacturer's protocol (ADP/ATP Ratio Assay Kit, catalogue number: ab65313; Abcam).
Quinone extraction and analysis
The type and amount of quinone present in membranes of E. coli GNB10608 (MG1655 ndh::FRT nuoA::FRT) strain [37] and in the purified NDH-2s were determined by quinone extraction followed by reversed phase HPLC analysis. 10 and 30 nmol of NdhC and NdhF purified enzymes, together with 10 nmol of ubiquinone-10 (Q10) as an internal standard, were extracted with 3 ml of 6:4 methanol:petroleum ether by vortexing vigorously for 1 min (3 times). The mixture was allowed to sit for 10 min before vortexing again for an additional min, followed by centrifuging at 3000 rpm for 10 min. The pellet of 100 ml cell culture was resuspended with 3.3 ml water and extracted with 16.8 ml of 6:4 methanol:petroleum ether by vortexing vigorously for 1 min (3 times). The mixture was allowed to sit for 2 h before vortexing again for an additional min, followed by centrifuging at 3000 rpm for 10 min.
The upper organic layer was removed to a fresh flask, and the remaining mixture was subjected to further extraction two more times with 10 min incubation each. The organic phase was then evaporated under a nitrogen stream, and the dried, oily residue was re-dissolved in 4:3:3 ethanol:methanol:acetonitrile. The extracted quinones were analyzed using a reversed phase Microsorb-MV 100-5 C18 HPLC column (Varian, Palo Alto, CA) on a Beckman System Gold HPLC system fitted with a diode array detector, and monitored at 278 nm. The mobile phase was 4:3:3 ethanol:methanol:acetonitrile. The type of quinone present in the membranes was determined based on the elution of quinone standards. The amounts were calculated from the ratio of the peak areas.
Inverted membrane vesicles (IMVs)
IMVs of E. coli were prepared by three passages through a precooled French pressure cell at 20,000 psi. The lysate was centrifuged at 14,000 ×g at 4°C for 20 min to remove unbroken cells. The supernatant was centrifuged at 370,000 ×g at 4°C for 1 h and the pellet consisting of the IMVs was washed with 50 mM MOPS-KOH (pH 7.5), 2 mM MgCl 2 . After the second centrifugation step, the membranes were resuspended in 50 mM MOPS-KOH (pH 7.5), 2 mM MgCl 2 , 10% glycerol and stored at − 80°C.
Assay for ATP or succinate-driven proton translocation
Proton translocation into IMVs of E. coli was measured by a decrease of 9-amino-6-chloro-2-methoxyacridine (ACMA) fluorescence. The excitation and emission wavelengths were 410 nm and 480 nm, respectively. IMVs (0.1 mg/ml membrane protein) were preincubated at 37°C in 10 mM HEPES-KOH (pH 7.5), 100 mM KCl, 5 mM MgCl 2 containing 2 μM ACMA and the baseline was monitored for a few minutes. The reaction was then started by adding 1 mM ATP or 5 mM succinate. When the signal was stabilized, different TZ concentrations were added.
Determination of transmembrane Δψ
The Δψ-sensitive fluorophore Oxonol VI 1,5-Bis(5-oxo-3propylisoxazol-4-yl)pentamethine oxonol was used to determine if TZ was able to dissipate the membrane potential in IMVs. E. coli IMVs (0.1 mg/ml membrane protein) were added to the assay buffer; 10 mM MOPS-KOH pH 7.5, 2 mM MgCl 2 , 2 μM Oxonol VI. After a few seconds, 0.5 mM NADH was added to initiate respiration-dependent generation of Δψ (positive inside) and the resultant quenching of Oxonol VI fluorescence was monitored at 37°C. The emission and excitation wavelengths were 599 nm and 634 nm, respectively. Uncoupling effect was estimated on the basis of its ability to dissipate the established Δψ, recorded as a dequenching of the fluorescence signal.
Results
Sequence analysis
Inspection of the genome of the S. aureus RF122 strain [38] indicates the presence of genes for succinate and malate dehydrogenases, two types of menaquinol oxidases (aa 3 -and bd-type respiratory oxygen reductases) and a nitrate reductase. There are no operons encoding for either Complex I (the energy-coupled NADH:quinone oxidoreductase) or Complex III (the quinone:cytochrome c oxidoreductase or bc 1 complex). NDH-2s have a very low sequence identity among each other, and are, therefore, difficult to reliably identify by amino acid sequence analysis alone. Enzymological characterization is always necessary. NDH-2s are characterized by the presence of (1) two GXGXXG motifs that are present at the binding sites for adenine dinucleotides [39, 40] ; and (2) one or two predicted amphipathic helices at the C-terminus [6, 8] . Two candidate genes meet these criteria in the S. aureus genome and both genes are shown in this work to encode authentic NDH-2s. They will be referred to as ndhF, encoding the protein NdhF (NCBI gi: 3793682; SAB0804c) and ndhC, encoding the protein NdhC (NCBI gi: 3793685; SAB0807). NdhF and NdhC have a sequence similarity of 45%. Both NdhF and NdhC contain the two conserved GXGXXG motifs. NdhF has the first motif starting at amino acid 8 and the second motif starting at amino acid 147, and NdhC has the first motif at amino acid 12 and the second motif at amino acid 165. By using the PSIPRED (v3.0) software, one C-terminal amphipathic helix was predicted for NdhF, extended from amino acid 336 to 352 and two C-terminal amphipathic helices for NdhC, one extending from amino acid 372 to 390 and the other from amino acid 393 to398.
Gene expression and protein purification
The cloned ndhF and ndhC genes were expressed heterologously in E. coli C43(DE3). Both C-and N-terminus 8His-tag constructions were made for each, but the NdhF protein was obtained only with the N-terminal His-tag, whereas NdhC protein was obtained only with the C-terminal His-tag.
The purity and size of the isolated proteins were analyzed by SDS-PAGE ( Fig. 1A ). Both NdhF (Fig. 1A, lane 1) and NdhC (Fig. 1A , lane 2) run near their predicted molecular weights of~40 kDa. The UV-visible spectra of the air-oxidized NdhF and NdhC proteins ( Fig. 1B and C) show the presence of FAD, each with a peak near 450 nm and a shoulder at 465 nm indicating that the cofactor is in an apolar environment in each protein [41] . The spectrum of NdhC is typical for flavoproteins with a peak around 450 nm [42] . The spectrum NdhF at pH 7.5 shows an additional broad absorbance centered at about 550 nm (Fig. 1B) . The additional absorption band results in a brick-red color of the solution of NdhF, compared to the typical yellow color of flavoproteins (including NdhC). As the solution of NdhF is made more acidic, down to pH 5, the peak at 550 nm disappears, the color changes to yellow, and the major peak shifts from 452 nm to 445 nm ( Fig. S1 ).
Precipitation of each protein with 5% tricholoracetic acid leaves the FAD cofactor in solution, demonstrating that it is not covalently bound [43] . The amount of flavin bound to the recombinant NdhF protein was calculated to be 0.5 mol FAD/mol protein, and for NdhC was 0.25 mol FAD/mol protein. FAD loss is a common issue for flavoproteins that are heterologously expressed [44] [45] [46] . Additionally, the quinone content of NdhC and NdhF was analyzed by HPLC, and was always less than 0.03 mol quinone/mol protein.
Enzymatic characterization
The NADH:quinone oxidoreductase activities of the purified NdhF and NdhC proteins were examined with 50 μM of several soluble quinones as oxidants: menadione (MD), duroquinone (DQ), ubiquinone-1 (Q1), ubiquinone-2 (Q2), decylubiquinone (DUQ) and 2,3-dimethyl naphthoquinone (DMN) (Figs. 2 and S2). Since both proteins produced in E. coli have sub-stoichiometric amounts of FAD, the assays were performed in the presence of 20 μM FAD in the reaction mix. The activity of both the enzymes increased significantly when FAD as well as a lipid mixture (125 μg/ml asolectin) were added to the reaction. The increase of the specific activity corresponds roughly to full incorporation of the lost FAD cofactor. The addition of FAD or lipids separately does not increase the enzyme activity (395 ± 24 NADH s −1 for NdhC and 134 ± 12 NADH s −1 for NdhF), but when both lipids and FAD are added enzyme activity increases by an amount consistent with full incorporation of FAD into the apo-enzymes present (1500 ± 85 NADH s −1 for NdhC and 240 ± 17 NADH s −1 for NdhF). The assay buffer also contains detergent (0.05% DDM) since both NdhC and NdhF are membrane proteins. In addition, the NaCl concentration is important both for maximal protein activity and stability. NdhC is unstable at 37°C in buffer containing less than 125 mM NaCl and in the absence of lipids. On the other hand, NdhF activity was optimal at lower concentrations of NaCl (50-100 mM) ( Table 1) .
The natural oxidant of both NdhF and NdhC is menaquinone in the S. aureus membrane [47] . In order to assay the activities of these enzymes under more native-like conditions, a protocol was devised to reconstitute the purified enzymes with E. coli membranes which lack endogenous NADH oxidase activity. E. coli membranes were isolated from a strain which lacks both NDH-2 and Complex I (Δndh Δnuo) [37] . The quinone content of these membranes was determined by quinone extraction and HPLC analysis. The membranes used for these experiments were from cells grown under conditions where the major quinone present is ubiquinone-8 (Q8) (Fig. S3A ). This result is consistent with previous studies [48] (Fig. S3B ). NADH oxidase activity of the Δndh Δnuo membranes is negligible, measured either by the oxidation of NADH or oxygen utilization. However, under the same conditions in the presence of 10 mM Na-succinate as electron donor, substantial oxygen utilization is observed (207 ± 12 μmol O 2 mg −1 protein s −1 ). By the addition of a sufficient amount of E. coli membranes and by inclusion of FAD in the assay buffer, the maximum activities of the S. aureus NDH-2 enzymes were determined using Q8 as the electron acceptor. In Fig. 2 , the specific activities of both enzymes are shown to be in the same range when the long chain quinone is used as the electron acceptor as when using the soluble quinone analogues. The NADH oxidation activities are increased significantly in the presence of exogenously added FAD, similar to what is observed when phospholipids are added to the assays with soluble quinone substrates. As expected, the same turnover numbers were obtained by monitoring either the oxidation of NADH spectrophotometrically or by measuring oxygen uptake using the oxygraph (corrected for 2 NADH oxidized per O 2 reduced). The data show that the isolated enzymes are competent to bind to the membrane and rapidly reduce a membrane-confined long chain quinone, and that both of the S. aureus NDH-2 enzymes can use either ubiquinones or menaquinones as electron acceptors.
For convenience, further steady state kinetics characterization was performed using the soluble analogue DMN ( 
Inhibition of the NDH-2 activity by phenothiazines
M. tuberculosis NDH-2 has been shown to be inhibited by phenothiazine [14, 24] . However, the effects of phenothiazines on NDH-2s from other pathogens have not been explored. The inhibitory effects of different phenothiazine compounds on the enzyme activities of the two purified S. aureus NDH-2s were examined using either DMN as the electron acceptor in detergent solutions, or by coupling the enzymes to the E. coli respiratory chain in the absence of detergents (Tables 2  and 3 ). The phenothiazines were found to be more potent inhibitors when assaying the enzymes using E. coli membranes ( Table 2) , and this assay was used for most experiments (Table 3) .
Three different phenothiazines were examined: TPZ, TZ and CPZ (see Table 3 ). Each was able to inhibit at least one of the two S. aureus NDH-2 enzymes, with 50% inhibition (IC 50 ) in the 10-30 μM range (Table 3 ). Despite the apparent similarities of these two enzymes, there must be subtle structural differences leading to differences in the way the inhibitors bind to the proteins. The best of the three inhibitors is thioridazine (TZ; see Table 3 ). To be certain that the NDH-2 enzymes were the actual targets of the inhibitors in the coupled assay with E. coli membranes, the same experiments were repeated using10 mM Na-succinate in place of NADH as the electron source and monitoring oxygen utilization. No inhibition was observed, indicating that the phenothiazines (up to 50 μM) are not inhibiting either E. coli succinate dehydrogenase or the E. coli respiratory oxygen reductases.
The effects of phenothiazines on S. aureus membranes
Membranes of S. aureus were obtained from cells grown for 14 h at 37°C, 200 rpm. The steady-state rate of respiration of S. aureus membranes was determined in a cell-free amperometric assay. NADH addition to the membranes (~200 μg/ml) results in the consumption of oxygen that is fully inhibited by the addition of 50 μM of either TZ or TPZ ( Table 4 ). The IC 50 for S. aureus membranes with either drug, TZ or TPZ, is similar to those obtained with the purified NdhC protein coupled to E. coli respiratory chain (Tables 3 and 4 ). Since TPZ does not inhibit NdhF, it is concluded that when S. aureus is grown under these conditions, the NDH-2 present is predominantly NdhC. NADH-driven respiration of membranes is mostly inhibited by the addition of 50 μM TPZ (8 ± 1 μmol O 2 mg −1 protein s −1 ), but is restored to the uninhibited activity (659 ± 28 μmol O 2 mg −1 protein s −1 ) by the addition of purified NdhF (736 ± 30 μmol O 2 mg −1 protein s −1 ), which reconstitutes with the S. aureus membranes, feeding electrons to the menaquinone pool and, from there, to the terminal oxygen reductases. The recovery of oxygen consumption implies that the site of inhibition by phenothiazines is upstream of the menaquinol-oxidases. Oxygen consumption was also examined using other electron donors: 10 mM DL-lactate, 10 mM Na-succinate and 10 mM DL-malate. There was no detectable oxygen consumption activity with either succinate or malate, and oxidase activity with DL-lactate was about 4-fold lower than with NADH. The DL-lactate oxidase activity was not inhibited by the phenothiazines but could be 75% inhibited by 2 mM KCN ( Table 4 ). The fact that the respiration is not completely inhibited by 2 mM KCN suggests the presence of a cyanide-resistant cytochrome bd in the S. aureus membranes. This was confirmed spectroscopically by obtaining the NADH-reduced minus air-oxidized spectrum of S. aureus membranes (Fig. S4 ). Peaks were observed at 427 nm, 532 nm and 556 nm, which could represent both b-type cytochromes, 444 nm and 603 nm, corresponding to the aa 3 -type oxygen reductase, and a heme d peak at 632 nm [49, 50] . Using NADH as electron donor, oxygen consumption was inhibited 70% by the addition of 100 μM KCN. It is concluded that when grown as described, the membranes of S. aureus contain both the aa 3 -type and bd-type menaquinol oxidases ( Fig. S4 and Table 4 ).
Collapse of the membrane potential and ATP depletion
It has been established that NDH-2 indirectly contributes to the proton motive force in aerobic and hypoxic M. tuberculosis and that thioridazine treatment of M. tuberculosis causes a collapse of the membrane potential, resulting in a concomitant reduction of ATP levels as well as an increase in the intracellular NADH/NAD + ratio [51] . Therefore, we investigated the effects of TZ treatment of S. aureus cells on the membrane potential and ATP/ADP ratio (Fig. 3) . Accumulation, leading to fluorescence quenching of the membrane-permeant cation DisC3 (5) was used to measure the transmembrane electrical potential of intact cells in suspension. Controls to validate this method with S. aureus cells were performed by adding either 3 mM cyanide or 1 μM of the uncoupler CCCP to the cell suspension. Each treatment resulted in the rapid collapse of the membrane potential, indicated by an immediate increase of the DisC3(5) fluorescence intensity.
The addition of thioridazine to S. aureus cells also resulted in an immediate increase in DisC3(5) fluorescence, indicating collapse of the membrane potential and release of the accumulated DisC3 (5) . The concentration-dependence of this effect is shown in Fig. 3A . Depletion of the ATP pool followed the collapse of the proton motive force, but higher TZ concentrations and a long incubation time (60 min) were necessary to observe a significant change in the ATP/ADP ratios (Fig. 3B) .
Inhibition of respiration of the cell suspension was also measured (Fig. 3C) under the same conditions used to measure the membrane potential. Surprisingly, in the presence of 50 μM TZ, which results in a rapid collapse of the membrane potential (Fig. 3A) , there is virtually no inhibition of cell respiration. Inhibition of aerobic respiration in intact cells by TZ is observed only at concentrations well over 100 μM (Fig. 3C) . However, when the same experiment is repeated in the presence of 1 μM CCCP, an uncoupler of oxidative phosphorylation, the addition of 50 μM TZ is sufficient to inhibit over 80% of aerobic respiration, which is completely inhibited by 100 μM TZ. This suggests that the phenothiazine TZ is being actively pumped out of S. aureus cells by efflux pumps, which are disabled by the presence of the protonophore CCCP. It is well established that efflux pumps are an important contributing factor to drug resistance in S. aureus [52] . When the efflux pumps are disabled, the intracellular concentration of TZ increases to a point where respiration by NdhC is inhibited. The data are consistent with, but do not definitively prove that NdhC is responsible for virtually all of the aerobic respiration by S. aureus under the growth conditions employed. Further work will be needed to further examine this.
Thioridazine is a lipophilic weak acid with a pK a of 8.89 [53] , and has been shown to be a weak uncoupler of oxidative phosphorylation with isolated rat liver mitochondria [54] . The uncoupler activity was confirmed by examining the effect of TZ on the energization of E. coli inverted membrane vesicles. In this system, the active site for ATP hydrolysis by the F 1 F o -ATP synthase is facing the external solution, as is the site for succinate oxidation by succinate:quinone oxidoreductase (succinate dehydrogenase/complex II). The addition of either ATP or succinate to the suspension of inverted membrane vesicles results in active proton pumping into the vesicle, corresponding to what would normally be proton pumping out of the cell. This leads to acidification of the small vesicle interior, and this acidification is monitored by the fluorescent dye ACMA (9-amino-6-chloro-2-methoxy acridine) [55] which is present in the solution. As observed in Fig. 4 , the protonation of ACMA inside the acidic vesicles results in accumulation of the dye and, consequently, in fluorescence quenching [55, 56] . The addition of an uncoupler (SF6847) or an inhibitor of respiration (KCN) or an inhibitor of the ATP synthase (DCCD) results in collapse of the pH gradient across the membrane and, consequently, the equilibration of the ACMA concentrations on the inside and outside of the vesicles (Fig. S5) . As a result, a rapid increase of the fluorescence from ACMA, which is no longer sequestered inside the vesicles, is observed. Fig. 4 shows that 3 μM TZ is sufficient to completely collapse the pH gradient in the inverted membrane vesicles, whether this is generated by the ATPase or by succinate-driven respiration. As a complementary assay, Δψ was determined in the presence of TZ and the known uncoupler SF6847 by using the fluorescence dye Oxonol VI. Oxonol VI is an anionic slow-response probe, which exhibits potential-dependent changes in its transmembrane distribution that is accompanied by a fluorescence change [57] . Fig. 5 shows that the membrane potential is completely dissipated upon the addition of 10 μM TZ. Hence, in addition to being an inhibitor of both of the NDH-2 enzymes in S. aureus, TZ is also an uncoupler of oxidative phosphorylation as previously suggested [58] .
Discussion
The current work is inspired by the recent approval of the anti-TB drug, TMC207, which inhibits the membrane-bound ATP synthase in M. tuberculosis, leading to the depletion of energy that is necessary for both the replicative as well as persistent states [15] . The ATP synthase is driven by the proton motive force across the cytoplasmic membrane which, in aerobic organisms, is driven by aerobic respiration. Hence, drugs targeted to the aerobic respiratory chain should be considered, particularly when pathogens have respiratory enzymes that are distinctly different from those in the mitochondrion. This is the case for the type-2 NADH dehydrogenase, or NDH-2, which is an important respiratory component in a number of pathogens but not present in the mammalian mitochondrial respiratory chain [14, 16, 18, 19] . Indeed, NDH-2 is actively being pursued as a possible drug target against M. tuberculosis [14] [15] [16] [17] , P. falciparum [18] and T. gondii [13, 19] . Although NDH-2 is often present in organisms that also contain alternative NADH oxidizing respiratory enzymes, either Complex I or the sodiumpumping NADH:quinone oxidoreductase, in some pathogens, NDH-2 is the only respiratory NADH dehydrogenase present. This is the case for S. aureus, whose genome encodes two putative NDH-2s. It is very likely that the function of at least one of the NDH-2s will be essential for S. aureus to survive under conditions where it relies on energy production from either aerobic or anaerobic (e.g., nitrate) respiration. It was recently reported that aerobic respiration is required for full S. aureus pathogenesis [59] . Strains of S. aureus that are unable to synthesize menaquinone and/or heme, although unable to respire, can survive by fermentation in a near dormant state. These respiration-impaired SCVs (small colony variants) are etiological agents of persistent infections [59] . It is not clear whether the inhibition of both NDH-2s in S. aureus would impact the survival of these small colony variants.
Two S. aureus NDH-2s
We have shown that each of the two genes annotated as NDH-2 in the S. aureus genome does encode an authentic NDH-2, denoted NdhC and NdhF. Both enzymes were produced by heterologous gene expression in E. coli and were shown to oxidize NADH and reduce a variety of quinones. The steady state kinetic parameters (Table 1) are different for the two enzymes though the physiological consequences are not known. Under the growth conditions employed in this work, NdhC appears to be the dominant NDH-2 present in S. aureus membranes, and this enzyme has a 6-fold higher k cat with DMN as the electron acceptor and 4-fold lower K M for NADH than NdhF. The k cat of NdhC (1500 NADH s − 1 ) is substantially higher than those reported for NDH-2s isolated from other bacterial sources. For example, E. coli has an k cat of~18 NADH s −1 [8, 10] , M. tuberculosis of~10 NADH s −1 [27] , Bacillus pseudofirmus of~39 NADH s − 1 [60] , Thermus thermophilus of 1 NADH s −1 [45] , Gluconobacter oxydans of~9 NADH s −1 [61] , and Corynebacterium glutamicum of~213 NADH s −1 [62] .
The red color of NdhF
Conditions under which NdhF would be present in the S. aureus membrane are not known. Compared to a regular flavoprotein spectrum [42] , the oxidized form of purified NdhF has an unusual red color due to an absorbance band at about 550 nm. This absorbance is similar to what has been reported for flavoprotein disulfide reductases [63, 64] and has been ascribed, in the AhpF protein [65] , to a thiolate-FAD charge transfer band arising from the interaction with a cysteine near the C4a position of the flavin ring. This is likely also the case for NdhF, which contains 3 Cys.
A new assay for NDH-2
Because NDH-2 normally functions on the surface of a membrane bilayer using long-chain quinones as substrate, an assay was developed to more closely mimic this situation. The purified NDH-2 enzymes from S. aureus are readily reconstituted with E. coli membranes and efficiently deliver electrons to the quinone pool, resulting in aerobic respiration. The addition of FAD to the reaction mix increases the reconstituted NADH oxidase activity, indicating that the FAD is incorporated to that portion of the recombinant protein which is purified without bound flavin thereby restoring activity. This assay avoids possible artifacts that might arise from the use of soluble quinone analogues, and can be used to better evaluate hydrophobic inhibitors. The success of this assay also implies that the two S. aureus NDH-2 enzymes do not require S. aureus phospholipids to bind to the membrane. Furthermore, this assay demonstrates that both enzymes can use long chain ubiquinone-8 (dominant in aerobically grown E. coli) as well as menaquinone-8 (present in S. aureus) as the electron acceptor. Membranes from E. coli were used rather than from S. aureus because of the availability of E. coli strains lacking endogenous membrane-bound NADH oxidase activity. The reconstitution also works with S. aureus membranes, but one needs to subtract a substantial background activity due to the presence of the NDH-2 enzymes in the membranes.
Phenothiazines inhibit both S. aureus NDH-2 enzymes
Phenothiazines are used in the clinic as neuroleptic antipsychotic drugs, but are also known to have antimicrobial activities [28, 66, 67] . Although they cause significant side effects, phenothiazines may offer a potential therapeutic use in problematic infections caused by antibioticresistant bacteria, particularly in combination with other antibiotics [68] [69] [70] . Phenothiazines inhibit M. tuberculosis NDH-2, which is a key enzyme in the M. tuberculosis respiratory chain [14, 17, 24, 27] , consistent with the transcriptional profile analysis which indicates that they act as respiratory poisons [71] . In the current work, it is shown that phenothiazines also inhibit the NDH-2 enzymes present in S. aureus, with the most potent being thioridazine, which inhibits both NdhC (IC 50 = 8 μM) and NdhF (IC 50 = 14 μM). This demonstrates that it is possible to obtain drugs that block both of these enzymes, enhancing the likelihood that drugs based on NDH-2 as a target could be therapeutically effective.
Phenothiazines are also uncouplers of oxidative phosphorylation
Although phenothiazines are effective inhibitors of the NDH-2 enzymes in vitro, they are not effective inhibitors with intact cells because the drugs are pumped out by efflux pumps. This is demonstrated by showing that the presence of 1 μM CCCP, a protonophore uncoupler which collapses the proton motive force, substantially increases the efficacy of thioridazine to inhibit cellular respiration (Fig. 3C ). Thioridazine must be pumped out by one or more efflux pumps that are driven by the proton motive force.
Phenothiazines themselves are known to inhibit the function of some of the energy-dependent efflux pumps from Mycobacterial species, including M. tuberculosis [69, 72] , as well as S. aureus efflux pumps [52, 58, 73] . For this reason, phenothiazines can be used to reverse the resistance to other antibiotics [69, 72] . Thioridazine (TZ; Table 3 ), which is less toxic to humans than chlorpromazine [74] , can be used in combination with other antibiotics (e.g., oxacillin) to kill MRSA as well as M. tuberculosis at concentrations that are tolerable in humans and can be clinically applied [58, 75, 76] .
At least 14 efflux pumps have been described for S. aureus [52] , and they are involved in several physiological processes, such as cell wall division, the maintenance of pH homeostasis and secretion of intracellular metabolites [77] . These pumps are driven either directly by ATP hydrolysis or by proton-flux under the control of the proton motive force [52, 78, 79] . The mechanism of inhibition may involve direct interactions with specific efflux pump proteins or may depend in part on reducing the magnitude of the proton motive force, and may be strain dependent [58] .
The current work demonstrates that the addition of 50 μM TZ to a suspension of S. aureus cells, under the conditions assayed, results in the collapse of the membrane potential, which will rapidly stop from functioning any of the efflux pumps that rely directly on the proton motive force. The concentrations of phenothiazines necessary to inhibit the growth of S. aureus are in the same range needed to collapse the membrane potential. The reported MIC values for inhibition of growth by TZ and TPZ are 40-60 μM and that by CPZ is 90-125 μM [28, 80] .
The MIC values obtained in the current work are somewhat higher ( Table 5 ) but still in the range of concentrations required for 100% collapse of the membrane potential (Fig. 3A) . As previously recognized, the inactivation of efflux pumps would explain the fact that phenothiazines synergize with other antibiotics by reducing the rate at which they are being pumped out of the cell [58] . The current demonstration of the uncoupling activity of phenothiazines is also consistent with a previous report that phenothiazines act as modest uncouplers of isolated rat liver mitochondria [54] . Mitochondrial uncoupling may relate to both the therapeutic mode of action of phenothiazines as well as their toxicity.
It is paradoxical that although 50 μM TZ is sufficient to collapse the membrane potential, the intracellular concentration does not get high enough to inhibit cell respiration, whereas the presence of 1 μM CCCP allows TZ to accumulate in cells to the extent that 50 μM TZ largely eliminates cell respiration (Fig. 3 ). This can be explained if TZ is acting as a protonophore and the protonated, cationic form is the major current carrier across the cell membrane in response to the active proton pumps. The uncoupling mechanism requires that the neutral form of the uncoupler cross the membrane in the opposite direction (inside to outside) of the protonated form. The steady state intracellular concentration of the uncoupler will depend on the rates of the multiple kinetic steps involved. It is feasible that even under the steady state conditions where the cyclic flux of TZ is sufficient to collapse the membrane potential, the intracellular TZ concentration will not be sufficiently high to inhibit the NDH-2 enzymes. If, on the other hand, CCCP is also present, then CCCP becomes the dominant current carrier, collapsing the proton motive force, and the TZ can accumulate due to the absence of the functional efflux pumps. Whether this speculation is correct will require additional studies on the mechanism by which the phenothiazines appear to act as uncouplers. Data are expressed as average ± SD of four independent experiments. The MIC is the lowest concentration of the compound required to eliminate visible growth in liquid culture under conditions described in the text.
